AAAAAA
Results:
1-10
|
Results: 10
Authors:
Ahsan, N
Johnson, C
Gonwa, T
Halloran, P
Stegall, M
Hardy, M
Metzger, R
Shield, C
Rocher, L
Scandling, J
Sorensen, J
Mulloy, L
Light, J
Corwin, C
Danovitch, G
Wachs, M
VanVeldhuisen, P
Salm, K
Tolzman, D
Fitzsimmons, WE
Citation: N. Ahsan et al., Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years, TRANSPLANT, 72(2), 2001, pp. 245-250
Authors:
Razzaque, MS
Hossain, MA
Ahsan, N
Taguchi, T
Citation: Ms. Razzaque et al., Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity, NEPHRON, 89(3), 2001, pp. 251-254
Authors:
Gupta, M
Haluck, RS
Yang, HC
Holman, MJ
Ahsan, N
Citation: M. Gupta et al., Laparoscopic-assisted renal biopsy: An alternative to open approach, AM J KIDNEY, 36(3), 2000, pp. 636-639
Authors:
Gupta, M
Miller, BA
Ahsan, N
Ulsh, PJ
Zhang, MY
Cheung, JY
Yang, HC
Citation: M. Gupta et al., Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis, TRANSPLANT, 70(8), 2000, pp. 1188-1194
Authors:
Johnson, C
Ahsan, N
Gonwa, T
Halloran, P
Stegall, M
Hardy, M
Metzger, R
Shield, C
Rocher, L
Scandling, J
Sorensen, J
Mulloy, L
Light, J
Corwin, C
Danovitch, G
Wachs, M
VanVeldhuisen, P
Salm, K
Tolzman, D
Fitzsimmons, WE
Citation: C. Johnson et al., Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation, TRANSPLANT, 69(5), 2000, pp. 834-841
Authors:
Razzaque, MS
Ahsan, N
Taguchi, T
Citation: Ms. Razzaque et al., Heat shock protein 47 in renal scarring, NEPHRON, 86(3), 2000, pp. 339-341
Authors:
Yang, HC
Holman, MJ
Langhoff, E
Ulsh, PJ
Dellock, CA
Gupta, M
Ahsan, N
Citation: Hc. Yang et al., Tacrolimus "low-dose" mycophenolate mofetil versus microemulsion cyclosporine "low-dose" mycophenolate mofetil after kidney transplantation - 1-year follow-up of a prospective, randomized clinical trial, TRANSPLAN P, 31(1-2), 1999, pp. 1121-1124
Authors:
Yang, HC
Holman, MJ
Langhoff, E
Dellock, CA
Gupta, M
Ulsh, PJ
Ahsan, N
Citation: Hc. Yang et al., A comparative study of 500 mg BID and 250 mg BID of prophylactic oral ganciclovir in post-kidney transplant "CMV at risk" recipients, TRANSPLAN P, 31(1-2), 1999, pp. 1125-1126
Authors:
Ahsan, N
Hricik, D
Matas, A
Rose, S
Tomlanovich, S
Wilkinson, A
Ewell, M
McIntosh, M
Stablein, D
Hodge, E
Hayes, D
Gores, P
Cohen, D
Gonwa, T
Brinler, K
Harland, R
Neylan, J
Pescovitz, M
Wynn, J
Ahsan, N
Yang, HC
Bennett, W
Copley, J
Wilkinson, A
Dunn, J
Tomlanovich, S
Chan, L
Bertolatus, JA
Weir, M
Mendez, R
Pirsch, J
Helderman, JH
Citation: N. Ahsan et al., Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study, TRANSPLANT, 68(12), 1999, pp. 1865-1874
Authors:
Ahsan, N
Citation: N. Ahsan, Intravenous infusion of total dose iron in peritoneal dialysis patients: Acritical appraisal - Author's reply, AM J KIDNEY, 32(6), 1998, pp. 1088-1090
Risultati:
1-10
|